# FDA Inspection 1121169 - Surmasis Pharmaceutical, LLC - March 19, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/surmasis-pharmaceutical-llc/9af114b0-9b1f-4a65-9868-a647531d81f8
Source feed: FDA_Inspections

> FDA Inspection 1121169 for Surmasis Pharmaceutical, LLC on March 19, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121169
- Company Name: Surmasis Pharmaceutical, LLC
- Inspection Date: 2020-03-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1277270 - 2025-08-01](https://www.globalkeysolutions.net/records/fda_inspections/surmasis-pharmaceutical-llc/5fb29e39-e823-41b8-9d3c-db716adf874c)
- [FDA Inspection 1042777 - 2018-03-01](https://www.globalkeysolutions.net/records/fda_inspections/surmasis-pharmaceutical-llc/2e115b4e-ec8a-4fdd-905a-b99b8dc377af)

Company: https://www.globalkeysolutions.net/companies/surmasis-pharmaceutical-llc/6f9dfe3c-c8c3-4740-b9a8-0ecc1bb9b400

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c